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Abstract 
Few cross-cultural measures are available to assess quality of life (QoL) in 
HIV/AIDS. A short form of the WHOQOL-HIV - the WHOQOL-HIV BREF - was 
developed and tested. Survey data from 1,923 HIV-positive adults (selected for age, 
gender and disease stage) were collected in 8 culturally diverse centres. The 'best' 
HIV-specific item was extracted from five HIV facets of the WHOQOL-HIV long 
form using information about item correlations with QoL, health and domains, item 
discriminant validity and centre problems. The five identified items were then 
integrated with the WHOQOL-BREF to complete the 31 item WHOQOL-HIV BREF. 
This short form shows good internal consistency reliability and discriminant validity 
for 'known' disease stages. Confirmatory factor analysis showed an overall good fit 
for a six domains model (Comparative Fit Index = .97), supporting scoring. Quality of 
life in different cultures is reported. A value of the WHOQOL-HIV short form is in 
monitoring QoL in multi-national clinical trials, and in clinical practice. 
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Introduction 
Despite the fact that there are 33.4 million people world-wide who are HIV-positive 
[1], relatively little is known about their quality of life (QoL). The recent global 
downturn in HIV infection rates [1] has not made the need for this information any 
less pressing. Quality of life assessment has a major role to play in evaluating 
outcomes from all types of interventions, from voluntary counselling and testing 
(VCT), to first and second line anti-retroviral treatments (ART), and new vaccination 
programmes. Furthermore, the QoL of untested people living in infected communities 
may well be affected [2]. Epidemic figures are now recorded by 158 countries [1], so 
comparing QoL in diverse cultures will require high quality, validated, culture-
sensitive measures to be available that are acceptable and interpretable to users. These 
are essential to identifying vulnerable persons, and indicating how best to improve 
their wellbeing. The purpose of this research was to create a short QoL measure that 
would be applicable and useful in this context. 
The number of measures designed to assess the QoL of those who are HIV positive is 
increasing; see review [3]. Although high quality instruments like the MOS-HIV are 
translated into various languages, advances in methodology developed by the 
WHOQOL Group have enabled language versions to become available that have 
greater equivalence between cultures than ever before [4]. Better semantic and 
conceptual equivalence improves metric equivalence, hence providing more reliable 
and valid data for comparative purposes. The WHOQOL-HIV is a multidimensional 
measure that was developed through a unique international collaboration whereby 
researchers from diverse cultures came together to pool and agree ‘universal’ 
concepts of QoL important to people with HIV. An international protocol for each 
stage of the qualitative and quantitative development work was developed by the 
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WHOQOL Group into a manual that is a ‘blueprint’ from which many subsequent 
language versions can be derived. During its development, focus groups of patients, 
health professionals and community members were held simultaneously in 
participating centres [5]. Pooled concepts and item wording they suggested informed 
the international measure and its local versions. Following a pilot, then a field-test 
survey of the WHOQOL-HIV, an HIV-specific module was included within the 
generic measure of the WHOQOL-100. Together, these complete a global QoL 
concept for people with HIV. The WHOQOL-100 was originally standardised for use 
with all diseases and conditions including well [6].   
The WHOQOL-HIV has several important features. First, it can be used to assess not 
just QoL outcomes from HIV infection but also diverse and multiple co-morbidities 
that accompany it, including opportunistic infections e.g. hepatitis C [7] and 
tuberculosis [8]. Second, as the WHOQOL-HIV can be completed by well people, it 
can assess the QoL of whole communities at risk from HIV infection e.g. carers, 
partners, truck drivers and sex workers. High levels of discriminant validity were 
previously found between well people and those a/symptomatic with HIV or AIDS 
[9]. Third, it can assess QoL at different disease stages, and in cases where multiple 
group identities are layered [10]. Fourth, special QoL assessments designed for use by 
particular subgroups e.g. injecting drug users, men who have sex with men, sex 
workers, will no longer need to be selected, as the WHOQOL-HIV can be used by 
everyone. This enables useful comparisons in changing circumstances. These features 
overcome losing comparative data because this instruments flexibility enables a 
common metric to be consistently applied across groups, and where repeated 
measures are needed. A short form of this cross-cultural instrument is valuable in sub-
Saharan Africa [2]. 
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This paper reports the development of a shorter version of the WHOQOL-HIV 
assessment: the WHOQOL-HIV short form. In line with the procedures used to derive 
a previous WHOQOL short form, the WHOQOL-BREF [11]; the ‘best’ item would 
be extracted from each facet of the WHOQOL-HIV. The aim of this study was to 
carry out the initial psychometric testing necessary to derive a WHOQOL-HIV BREF, 
and to report its global properties.    
Method 
Design 
Data from two surveys were used to select items for inclusion in the WHOQOL-HIV 
short form. This was previously published in separate studies as pilot data for the 
WHOQOL-HIV long form [12], and the WHOQOL-HIV field trial [9].  The merged 
dataset analysed in the present study contained the 120 items of the WHOQOL-HIV 
long form, and socio-demographic and health status information. The WHOQOL-HIV 
short form was extracted from this.  
Both surveys employed a quota sampling design where targets were 50% each for 
gender groups, age bands (> 30 years, < 30 years), and health status groups 
(sick/well). In the field trial, 33% of people with AIDS, symptomatic and 
asymptomatic-HIV were targeted. Pilot targets were 25% for three HIV-positive 
groups plus a fourth well group. People with AIDS had major signs of the disease e.g. 
Kaposi sarcoma, fever, weight loss, meningitis. Those with symptomatic-HIV showed 
minor signs of the disease. The asymptomatic group had an HIV-positive diagnosis, 
without any signs. 
Sample 
The total sample contained 2,225 participants of which 1,923 were analysed. Well 
participants who were not HIV-positive were excluded from all analyses, so 
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accounting for the reduced numbers. The pilot study contained data from six centres: 
Australia, Brazil, South and North India; Bangalore and New Delhi respectively, 
Thailand and Zimbabwe [12]. The field trial was conducted in seven centres and 
contained a second wave of data from five pilot centres (excluding Zimbabwe), and 
two new centres; Italy and Ukraine [9]. The combined global sample from eight 
centres therefore contained: 312 Australians, 343 Brazilians, 344 Indians from 
Bangalore and 187 from New Delhi, 186 Thais, 100 Zimbabweans, 151 Italians, and 
300 Ukrainians.  
The sample mean age was 33 years, and it contained more men (65.7%) than women. 
HIV status was fairly evenly distributed: HIV-asymptomatic (41.1%), HIV-
symptomatic (33.1%), and AIDS (24.8%). The sample percentages of the highest 
level of education completed were: 12.9% primary school, 49.0% secondary school, 
and 38.1% university. Differences between countries can be inspected in Table 1; the 
Australian sample was oldest and included most men.  
INSERT TABLE 1 HERE 
Instruments 
The WHOQOL-HIV long form contains 120 items organised in 30 facets or aspects 
of QoL. It is composed of the 100 generic items from the WHOQOL-100 plus 20 
HIV-specific items. The WHOQOL-100 is a cross-cultural, subjective self-report QoL 
instrument that was initially developed and tested in 15 countries world-wide. Six 
domains were identified: physical, psychological, level of independence, social, 
environmental, and spiritual QoL, containing 25 internationally agreed facets of QoL 
[13]. A general facet on overall QoL and health is not scored. Each facet contained 
four items. Socio-demographic questions in the WHOQOL instruments inquire about 
age, gender, educational level, marital status and health status. 
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The psychometric development of the WHOQOL-HIV followed the same procedures 
as the WHOQOL-100. Five additional facets of QoL were important to focus groups 
of people with HIV previously held simultaneously in six culturally diverse countries 
[5][12]. These new concepts were: symptoms of PLWHA (physical domain), social 
inclusion (social relationships domain), death and dying, fear of the future, and 
forgiveness (spiritual domain).  Items in all WHOQOL instruments are rated on five-
point Likert interval scales. Higher scores denote better QoL; domain scores range 
from 4 (poorest) to 20 (best). The WHOQOL-HIV long form was scored in the six 
domains of QoL originally proposed for the WHOQOL-100 [9][6].  
Five newly selected HIV items; one from each of the five HIV facets, would be 
incorporated into an existing short form instrument; the WHOQOL-BREF [11]. The 
WHOQOL-BREF contains 26 generic items extracted from the WHOQOL-100. Each 
item represents one of each of the 24 component facets of QoL; two others assess a 
general facet on overall QoL, and health [14][11]. The WHOQOL-HIV BREF would 
therefore contain a total of 31 items from 30 facets of QoL. It was expected that it 
would be scored in six domains, commensurate with the HIV long form.   
Procedure 
Item selection for the WHOQOL-HIV short form followed the protocol used to derive 
items of the WHQOOL-BREF from the WHOQOL-100 [14].  The selection decisions 
can be summarised as follows: (i) Included items would explain a substantial 
proportion of variance within general QoL and general health perceptions. (ii) Final 
assessment scores should be able to discriminate between identified or known groups 
of people; in this case, those at different stages of HIV progression.  
Data Preparation and Statistical Analysis 
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Centre data were first cleaned and checked before merging into the global dataset. 
Negatively phrased items, e.g.‘To what extent are you bothered by people blaming 
you for your HIV status?’ were recoded (e.g. a score of 5 was recoded as 1), so that 
higher scores consistently represented better QoL.  Mean facet and domain scores 
were calculated. Psychometric analyses for the WHOQOL-HIV short form replicated 
reliability, frequency, validity, and MAP analyses used to derive the WHOQOL-
BREF [14]. They include a test of internal consistency reliability of domains using 
standardised Cronbach’s alpha with systematic item deletion and replacement 
procedures. Discriminant validity was examined using one-way Analysis of Variance 
(ANOVAs) with post hoc comparisons (Scheffe) between three HIV-positive groups: 
a/symptomatic, AIDS.  To further examine construct validity, Confirmatory Factor 
Analysis (CFA) was used to investigate whether the six domains loaded onto a single 
(hypothetical) construct of QoL, as theoretically expected. This model was run twice, 
on two separate random halves of the data.  
Results 
Selection of items 
A series of tests were conducted on the WHOQOL-HIV items (see Table 2). First, to 
establish construct validity, each item was correlated with both general items on QoL 
and health. Inter-item correlations were expected to be best within their predicted 
facet, and with their respective domain score. Discriminant validity was tested for 
each item by HIV status (data not shown). Finally, problems for each centre relating 
to internal consistency (Cronbach’s alpha) and construct validity (inter-item 
correlations) were summarised. Items were highlighted with problematic alpha values 
(alpha <.70) or problematic inter-item correlations (r<.30). The results of these 
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analyses are summarised in Table 2 which illustrates bivariate correlations for each 
item, and highlights problems found within centres. 
These results showed that within each HIV facet, one item performed better than the 
others with its predicted domain, and with overall general QoL and health. Likewise, 
items mainly supported discriminant validity. Where item performance was marginal 
we considered important details; for example, in the case of f51.1 and f51.3, the 
former item discriminates between symptomatic patients vs. those with AIDS, but the 
latter does not. Decisions were also guided by procedures agreed by the WHOQOL 
Group [13]. Consequently the best items overall were selected to represent their HIV 
facet in the short form, and would be combined with other items from the WHOQOL-
BREF within their domain for scoring purposes. The items for the new WHOQOL-
HIV short form are presented as supplementary material in Table 4. 
INSERT TABLE 2 HERE 
Internal consistency reliability 
Cronbach’s alpha was calculated for each of six domains with the five HIV items 
included in their domain, as appropriate. For domains to show acceptable internal 
consistency reliability, it is recommended that alpha values of 0.70 or greater are 
found [15]. Results for the physical and social domains showed that adding HIV 
facets to these domains increased alpha from 0.65 to 0.72, and 0.69 to 0.72 
respectively, so making them acceptable. Including three HIV items into the spiritual 
domain resulted in an alpha of 0.69 which was slightly below the acceptance criterion 
of 0.70. Lastly, the three domains that did not include an HIV item covering 
psychological, independence and environmental QoL were acceptable, with alphas of 
0.74, 0.77, and 0.82 respectively. 
Discriminant Validity 
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It is important for the WHOQOL-HIV short form scores to distinguish between 
different stages of HIV disease progression. To test this, ANOVA was conducted on 
the facet and domain scores by disease status (asymptomatic, symptomatic and AIDS) 
(see Table 3). The results confirm that the new instrument shows very good 
discriminant validity. Thirteen out of 30 facets discriminated significantly between all 
three disease stages, as did five out of the six domain scores. Furthermore, all facet 
and domain scores except health and social care, significantly discriminated between 
asymptomatic-HIV and AIDS. Also all but three facets distinguished between 
asymptomatic and symptomatic HIV. The largest domain effects were for the physical 
(F. = 186.4) and level of independence (F. = 197.6) domains. In every significant case 
QoL decreased with disease progression, and effects were particularly strong for 
facets on dependence on medication and treatment (F. = 127.6), and working capacity 
(F. = 130.6). 
INSERT TABLE 4 HERE 
Construct Validity 
Confirmatory Factor Analysis was used to confirm whether as expected, all six 
domains would load onto a single QoL factor. The model for each half of the data was 
duplicated showing acceptable solutions with very similar fit indices. The CFI was 
good at .97; ² values showed improvements for this model (425.44, p <0.001) over 
the independence model (13643.41) (df = 326); also RMSEA (0.17) was acceptable 
(p<.001). Each path coefficient in the confirmatory factor analytic model was 
significantly different from zero. Figure 1 shows that all six domains loaded onto a 
single factor representing overall QoL. Contributions ranged from  = .65 
(environmental QoL), to  = .85 (psychological QoL), supporting the WHOQOL-HIV 
structure and its scoring. 
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INSERT FIGURE 1 HERE 
Centre Means 
Mean and standard deviation scores were calculated for each centre and the global 
data. Although the WHQOOL-HIV instruments were not designed to determine 
which countries have “better” QoL, these values identify the poorest areas of QoL so 
that they can be brought to the attention of policy makers. The supplementary material 
in Table 5 (available on-line) shows that QoL in many facets and domains was 
acceptable (values exceeding 3.0 on the 5–point scale) but not good (4.0). The poorest 
areas of QoL globally, were in general health, perceived financial resources, 
recreation and leisure and sex-life.  
 Scoring and access 
Analyses for the WHOQOL-HIV BREF are based on the six domain solution. The six 
domain scores for the WHOQOL-HIV BREF were calculated by multiplying the 
mean of all items within the domain by four. Potential scores for all domains therefore 
range from 4 to 20.  The official version of WHOQOL-HIV BREF is available in 
English at:  www.who.int/mental_health/media/   
The full scoring procedure is included in the WHOQOL-HIV manual which is 
available at: www.who.int/mental_health/evidence/WHOQOL-HIV 
Different language versions are available on request from the Principal WHOQOL-
HIV investigators in participating centres, who are named in this paper. 
 
Discussion 
This paper presents a short form of the WHOQOL-HIV; the WHOQOL-HIV BREF. 
Overall, this international instrument demonstrates sound psychometric properties that 
promise for a reliable and valid instrument in the future assessment of well-being in 
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PLWHA. The ‘best’ psychometric item was extracted from each of five HIV facets in 
the WHOQOL-HIV long form on the basis of their associations with general QoL and 
health, with their respective domains, and through demonstrating excellent 
discriminant validity. When combined with the WHOQOL-BREF items to complete a 
31-item WHOQOL-HIV BREF short form, items and domains of the new measure 
showed very good discriminant validity with reference to ‘known’ disease groups, and 
generally, very good internal consistency reliability.  
Quality of life for HIV-positive people in centres shows that the level is generally 
acceptable, but the profiled domain scores enable areas of unacceptable and poor QoL 
to be clearly identified where they exist. As empirical data are provided on these 
problematic areas, they can be targeted for future action by national, and international 
policy-makers, and at individual and group levels by health and development 
practitioners. 
Each part of the assessment makes an important contribution, and our model reaffirms 
six domains of QoL in HIV. However regression analysis of South African HIV data 
only identified 4 domains as important [16] and illustrates the danger of generalising 
global conclusions from data collected within a single nation. In the present research, 
every domain including spirituality, religiousness and personal beliefs (SRPB) made a 
significant contribution; SRPB is an issue which was seen as essential to a 
comprehensive assessment of QoL by previous WHOQOL-HIV focus groups [5] and 
survey respondents [9]. However, this domain largely remains invisible, and is 
ignored, or seen as irrelevant by health assessment researchers as demonstrated by its 
omission from most other HIV measures of QoL [3]. As our model shows that SRPB 
is a distinctive, valued component of QoL, health and social care practitioners should 
be careful not to shy away from addressing SRPB directly, as they will miss key 
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information that could enable the delivery of holistic care, and the satisfaction that 
this brings. Furthermore the model shows how central independence is to QoL in 
HIV. Although often subsumed within physical health in QoL assessments as 
‘functional status’, here our model shows that it is distinctive, and therefore warrants 
particular clinical attention in this population.  
One disadvantage of the WHOQOL-HIV long form was the need to complete 120 
items to provide a comprehensive assessment of QoL relating to health. Although the 
long form provides an in-depth analysis of well-being, and an exceptional breadth of 
concept for fine-grained research, the short form can give a ‘snap shot’ of QoL as this 
new assessment is quick and easy to complete. It can be self-assessed by literate 
respondents without visual impairment, or administered by an interviewer. Given the 
potential burden of longer QoL assessments for people with AIDS, there is merit in 
having access to a shorter form that captures the same comprehensive range of 
dimensions and does so reliably and validly. This short form WHOQOL-HIV will be 
invaluable in busy clinics where the burden of illness is severe and in multi-national 
clinical trials but can also be integrated into the HIV Behavioural Sentinel Surveys 
[17], to monitor risky behaviour and attitudes among target populations. In such 
instances, a short form could be used to assess the impact of large scale interventions 
such as behaviour change communications or increased access to ARVs, and help to 
determine its impact not only on the behaviour in question but also on the well-being 
of targeted populations. Used routinely as part of national monitoring, such an 
instrument could provide through its multiple domains a range of cross-culturally 
relevant indicators of well-being. Used within different countries such information 
could inform international monitoring and provide complementary indicators, in 
addition to the routine HIV behavioural indicators that are regularly used.  
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As official translations of WHOQOL measures have higher semantic and conceptual 
equivalence between language versions than other cross-cultural measures [18], this 
data will be invaluable in international comparisons of QoL in combating the HIV 
epidemic. The novel WHOQOL methodology has improved the validity of 
information collected by the WHOQOL-HIV BREF. By using multiple and 
simultaneous focus groups within countries, and expert working groups across 
countries, demonstrated sensitivity to the use of appropriate Likert interval scaled 
responses, and common protocols for cross-cultural pilot and field tests, this 
methodological approach provided the backbone to developing the WHOQOL-BREF. 
Through adding disease-specific facets to the generic assessment of QoL in HIV-
positive adults in order to complete a holistic concept of QoL for this disease, we find 
that this integrated instrument shows promising psychometric properties, building on 
an assessment that is already high quality.  
It is acknowledged that the WHOQOL-HIV BREF will now need to be assessed using 
fresh samples of data, including those gathered using longitudinal designs. Preferably, 
these should include more countries, especially from sub-Saharan Africa, where high 
quality data are not yet available [2]. The WHOQOL-HIV BREF also needs further 
validation, and across new cultures. Like other measures in this field, it will need 
revision periodically to keep pace with the changing nature of the epidemic, and its 
treatments.  
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Table 1: Features of centres contributing to the development of the WHQOOL-HIV BREF 
 
  Age HIV/AIDS Status Gender Educational level (highest) 
Centre N Mean 
age 
SD % No HIV 
Symptoms 
N= 844 
% HIV 
Symptoms  
n = 663 
% AIDS 
 
n = 415 
%  
Male 
n= 1271 
%  
Primary  
n = 342 
% 
 Secondary 
n = 888 
% 
University 
n = 589 
%  
Post-grad 
n = 104 
Australia 312 42.7 8.6 47.3 29.2 23.4 93.0   0.7 41.1 48.5  9.5 
Bangalore:India 344 30.8 7.9 35.1 32.8 31.9 61.6 36.9 38.6 21.5  2.9 
Brazil 343 34.9 8.6 42.6 33.0 24.3 61.9 12.7 61.6 24.3  1.2 
N.Delhi: India 187 30.5 6.1 48.7 20.7 30.4 82.9 13.4 28.6 50.6  7.3 
Italy 151 35.5 7.4 32.2 29.5 38.2 69.5 12.7 37.5 36.9 12.5 
Thailand 186 31.1 6.8 35.2 43.7 21.0 53.9 11.3 37.5 33.5 17.6 
Ukraine 300 28.1 7.4 50.0 41.8 8.2 50.0 1.0 85.0 13.3  0.7 
Zimbabwe 100 31.3 8.8 31.8 30.6 37.5 50.0 0.0 23.8 76.1  0.0 
TOTAL 1,923 33.4 9.8 41.1 33.1 24.8 65.7 12.9 49.0 32.4  5.7 
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Table 2: Testing the properties of the HIV items in the WHOQOL-HIV
3
. 
 Correlations (Pearson’s r) Alpha tests and inter-item correlations Discriminant validity* 
 
Overall Quality of 
Life g1 
Overall Health 
g4 
Correlation  with the 
General facet  
[g.1 & g.4] 
Inter-item 
correlation 
Number of countries 
with problematic 
alphas, by item 
Number of countries 
with problematic 
 inter-item correlations, 
by item 
Asymptomatic Symptomatic AIDS 
Symptoms  of PLWHA       Mean Mean Mean 
F50.2 To what extent do you fear possible future (physical) pain? .26 .29 .31 .47 2  3.00 (2.91, 3.08)
 a 2.70 (2.61, 2.79) b 2.49 (2.39, 2.60) c 
F50.1 (AF2.1) How much are you bothered by any unpleasant physical problems 
related to your HIV infection? 
.37 .40 .44 .66   3.57 (3.49, 3.66) a 2.97 (2.88, 3.07) b 2.67 (2.56, 2.77) c 
F50.3 (AF2.3) To what extent do any unpleasant physical problems prevent you 
from doing the things that are important to you? 
.34 .34 .39 .49 1 1 3.55 (3.47, 3.64) a 3.11 (3.02, 3.19) b 2.85 (2.75, 2.95) c 
F50.4 (AF2.4) To what extent are you bothered by fears of developing any physical 
problem? 
.32 .35 .38 .66   3.07 (2.99, 3.17) a 2. 67 (2.59, 2.77) b 2.49 (2.36, 2.58) c 
Social  Inclusion          
F51.1 (AF5.1) To what extent do you feel accepted by the people you know? .40 .32 .41 .61   3.40 (3.33, 3.48) a 3.26 (3.18, 3.34) b 3.08 (2.98, 3.19) c 
F51.2 (AF5.2) How often do you feel you are discriminated against because of your 
health condition? 
.35 .32 .38 .53 1 1 3.65 (3.57, 3.73) a 3.41(3.33, 3.50) b 3.21 (3.11, 3.32) c 
F51.3 (AF5.3) To what extent do you feel accepted by your community? .40 .32 .41 .61   3.16 (3.08, 3.23) a 2.99 (2.89, 3.06) b 2.90 (2.77, 2.97) b 
F51.4 (AF5.5) How much do you feel alienated from those around you? .36 .28 .36 .50 1  3.47 (3.35, 3.51) a 3.25 (3.17, 3.34) a 3.06 (2.95, 3.17) b 
Forgiveness          
F52.1 (AF7.2) How much do you blame yourself for your HIV infection? .26 .22 .27 .52 1 1 3.40 (3.30, 3.48) a 3.26 (3.18, 3.34) b 3.08 (2.98, 3.20) b 
F52.2 (AF7.3) To what extent are you bothered by people blaming you for your HIV 
status? 
.32 .28 .34 .73   3.31 (3.21, 3.40) a 3.16 (3.06, 3.27) a 2.99 (2.86, 3.13) b 
F52.3 (AF7.4) How guilty do you feel about being HIV positive? .28 .25 .30 .51 2 1 3.36 (3.27, 3.46) a 3.05 (2.94, 3.16) b 3.06 (2.93, 3.19) b 
F52.4 (SF6.8) To what extent do you feel guilty when you need the help and care of 
others? 
.25 .24 .28 .57   3.16 (3.07, 3.24) a 2.95 (2.86, 3.04) b 2.83 (2.71, 2.94) b 
Fear of Future          
F53.1 (AF8.1) To what extent are you concerned about your HIV status breaking 
your family line and your future generations? 
.23 .21 .25 .44 1 2 3.11 (3.03, 3.21) a 2.97 (2.86, 3.08) a 2.94 (2.81, 3.07) a 
F53.2 (AF8.2) To what extent are you concerned about how people will remember 
you when you are dead? 
.19 .22 .23 .48  2 3.40 (3.16, 3.35) a 3.25 (3.16, 3.35) a 3.03 (2.91, 3.16) b 
F53.3 (AF9.4) To what extent do any feelings that you are suffering from fate or 
destiny bother you? 
.31 .25 .31 .44  2 3.40(3.31, 3.49)  a 3.24(3.14, 3.33) b 3.11 (2.99, 3.23) b 
F53.4 (SF8.5) How much do you fear the future? 
.37 .33 .40 .57   3.30 (3.21, 3.38) a 3.05 (2.90, 3.10) b 2.82 (2.70, 2.94) c 
                                                 
3
 Statistical difference is labelled with a superscript, a, b, or c (p<0.05). Means with the same letter in their superscripts do not differ significantly from one another according UNIANOVA test, respectively (p<0.05).   
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Death &  Dying          
F54.1 (AF10.1) How much do you worry about death? .34 .31 .36 .75   3.45  93.36, 3.54) a 3.21 (3.10, 3.30) b 3.06 (2.92, 3.16) c 
F54.2 How bothered are you by the thought of not being able to die the way you 
want to? 
.28 .28 .32 .73   3.43 (3.34, 3.52) a 3.19 (3.09, 3.29) b 2.95 (2.83, 3.07) c 
F54.3 (AF10.6) How concerned are you about how, and where you will die? .29 .26 .32 .64   3.49 (3.40, 3.58) a 3.22 (3.12, 3.32) b 2.92 (2.80, 3.04) c 
F54.4 (AF10.7) How preoccupied are you about suffering before dying? .27 .26 .30 .66   3.18 (3.08, 3.27) a 2.94 (2.84, 3.04) b 2.55 (2.43, 2.66) c 
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Table 3: Discriminant validity of all items (facets) and domains included in the 
WHQOOL-HIV BREF
4
 
  
HIV 
Asymptomatic 
(1) 
 
HIV  
Symptomatic   
(2) 
 
AIDS  
 
(3) 
 
F 
Facets  N= 776 N= 643 N= 465  
Pain & Discomfort 3.78
 a
 3.23
 b
 2.84
 c
 99.12*** 
Energy & Fatigue 3.67
 a
 3.16
 b
 2.76
 c
 119.23*** 
Sleep & Rest 3.46
 a
 3.02
 b
 2.85
 c
 57.26*** 
Symptoms of PLWHA 3.57
 a
 3.00
 b
 2.75
 c
 101.87*** 
Positive Feelings 3.32
 a
 2.98
 b
 2.90
 b
 31.62*** 
Cognition 3.30
 a
 3.09
 b
 2.92
 b
 26.62*** 
Self-Esteem 3.52
 a
 3.23
 b
 3.12
 b
 28.67*** 
Body Image and Appearance 3.65
 a
 3.35
 b
 2.95
 c
 61.19*** 
Negative Feelings 3.41
 a
 3.10
 b
 2.90
 c
 44.09*** 
Mobility  3.96
 a
 3.58
 b
 3.13
 c
 105.88*** 
Activities of Living 3.72
 a
 3.26
 b
 3.07
 b
 74.02*** 
Dependence on Medication/Treatment 3.82
 a
 3.11
 b
 2.75
 c
 130.64*** 
Working Capacity  3.73
 a
 3.18 2.80
 c
 127.61*** 
Personal Relationships 3.49
 a
 3.30
 b
 3.25
 b
 9.17*** 
Social Support 3.40
 a
 3.16
 b
 3.06
 b
 18.76*** 
Sex Life 3.04
 a
 2.85
 ab
 2.63
 b
 19.11*** 
Social Inclusion 3.37
 a
 3.17
 b
 3.12
 b
 12.90*** 
Physical Safety & Security 3.17
 a
 3.01
 ab
 2.95
 b
 8.63*** 
                                                 
4
 Statistical difference is labelled with a superscript, a, b, or c (p<0.05). Means with the same letter in their superscripts do not differ significantly 
from one another according UNIANOVA test, respectively (p<0.05).   Asterisks shown in the final column provide the level of significance for the F 
value: ** p<.01; *** p<.001 
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Home Environment 3.53
 a
 3.35
 b
 3.28
 b
 10.99*** 
Financial Resources 2.66
 a
 2.42
 b
 2.25
 c
 23.47*** 
Access to Health & Social Care 3.40
 a
 3.26
 b
 3.28
 a b
 4.59** 
Opportunities for Information and  Skills 3.29
 a
 3.10
 b
 2.95
 c
 16.11*** 
Opportunities for Recreation and  Leisure 3.11
 a
 2.82
 b
 2.77
 b
 23.39*** 
Physical Environment 3.25
 a
 3.07
 b
 2.99
 b
 13.80*** 
Transport  3.34
 a
 3.17
 b
 3.18
 b
 6.96*** 
Spiritual  3.29
 a
 3.17
 a b
 3.03
 b
 8.98*** 
Forgiveness 3.27
 a
 3.18
 b
 2.92
 b
 7.75*** 
Fear of the Future 3.29
 a
 3.02
 b
 2.96
 b
 21.98*** 
Death & Dying 3.45
 a
 3.21
 b
 3.06
 b
 15.50*** 
General QoL 3.47
 a
 3.15
 b
 2.98
 c
 45.43*** 
General Health 3.27
 a
 2.77
 b
 2.56
 c
 84.97*** 
Domain Scores     
Physical Domain (1) 14.49
 a
 12.39
 b
 11.12
 c
 186.37*** 
Psychological Domain (2) 13.77
 a
 12.59
 b
 11.81
 c
 79.95*** 
Independence Domain (3) 15.25
 a
 13.14
 b
 11.75
 c
 197.63*** 
Social Relationships Domain (4) 13.30
 a
 12.56
 b
 12.00
 c
 25.41*** 
Environment Domain (5) 12.87
 a
 12.10
 b
 11.83
 b
 27.59*** 
Spirituality, Religion and Personal Beliefs 
(SRPB) Domain (6) 
13.35
 a
 12.53
 b
 11.85
 c
 26.78*** 
 
Key: *** p<0.001; ** p<.01 
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Figure 1: Testing the six domain structure of the WHOQOL-HIV BREF using 
Confirmatory Factor Analysis.   
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SUPPLEMENTARY TABLES 
Table 4: Thirty-one items of the final WHOQOL-HIV BREF instrument organised by 
domain (HIV items in bold). 
PHYSICAL DOMAIN 
(F1.4) To what extent do you feel that physical pain prevents you from doing what you need to do? 
(F2.1) Do you have enough energy for everyday life? 
 (F3.3)  How satisfied are you with your sleep? 
(F50.1)  How much are you bothered by any physical problems related to your HIV infection? 
PSYCHOLOGICAL DOMAIN 
(F4.1) How much do you enjoy life? 
(F5.3) How well are you able to concentrate? 
(F6.3) How satisfied are you with yourself? 
 (F7.1) Are you able to accept your bodily appearance? 
(F8.1) How often do you have negative feelings such as blue mood, despair, anxiety, depression? 
LEVEL OF INDEPENDENCE DOMAIN 
(F9.1) How well are you able to get around? 
(F10.3) How satisfied are you with your ability to perform your daily living activities? 
(F11.3) How much do you need any medical treatment to function in your daily life? 
(F12.4)  How satisfied are you with your capacity for work? 
SOCIAL RELATIONSHIPS  DOMAIN 
(F13.3) How satisfied are you with your personal relationships? 
(F14.4) How satisfied are you with the support you get from your friends? 
(F15.3)  How satisfied are you with your sex life? 
(F51.1)  To what extent do you feel accepted by the people you know? 
ENVIRONMENT DOMAIN 
 (F16.1)  How safe do you feel in your daily life? 
 (F17.3) How satisfied are you with the conditions of your living place? 
 (F18.1) Have you enough money to meet your needs? 
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 (F19.3) How satisfied are you with your access to health services? 
 (F20.1)  How available to you is the information that you need in your day-to-day life? 
 (F21.1)  To what extent do you have the opportunity for leisure activities? 
 (F22.1)  How healthy is your physical environment? 
 (F23.3)  How satisfied are you with your transport? 
SPIRITUALITY, RELIGION AND PERSONAL BELIEFS (SRPB) DOMAIN 
 (F24.2) To what extent do you feel your life to be meaningful? 
 (F52.2) To what extent are you bothered by people blaming you for your HIV status 
 (F53.4) How much do you fear the future? 
 (F54.1)  How much do you worry about death? 
GENERAL QUALITY OF LIFE 
 (G1) How would you rate your quality of life?  
 (G4) How satisfied are you with your health? 
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Table 5: Centre means and standard deviations for each facet and domain of the WHOQOL-HIV BREF 
Facets and Domains Global Australia Bangalore: India Brazil N.Delhi: India Italy Thailand Ukraine Zimbabwe 
Pain & Discomfort 3.35 1.24 3.64 1.24 3.53 1.23 3.16 1.26 3.79 1.12 3.97 1.09 2.73 1.01 3.22 1.03 2.25 1.29 
Energy & Fatigue 3.26 1.09 3.70 1.08 2.82 1.03 3.63 1.02 3.28 1.20 2.95 0.97 3.21 0.83 3.35 0.98 2.52 1.17 
Sleep & Rest 3.15 1.08 2.89 1.28 2.88 0.85 3.44 1.11 3.44 1.25 3.16 0.98 3.03 0.92 3.40 0.97 2.90 1.02 
Symptoms of PLWHA 3.15 1.20 3.60 1.25 2.94 1.23 3.16 1.26 3.60 1.18 3.44 0.89 2.69 1.08 3.13 0.95 2.22 1.21 
Positive Feelings 3.09 1.05 3.64 1.01 2.65 0.93 3.41 0.98 2.86 1.08 3.72 0.86 3.16 0.88 2.73 0.92 2.51 1.18 
Cognitions 3.12 0.91 3.39 0.79 2.88 0.97 3.25 0.88 2.86 1.04 2.82 0.87 3.26 0.81 3.25 0.76 2.92 1.13 
Self-Esteem 3.30 1.01 3.53 1.10 2.90 0.82 3.55 1.02 3.44 1.18 3.55 0.86 3.39 0.98 3.18 0.86 2.90 1.07 
Body Image 3.36 1.12 3.60 1.08 3.07 1.19 3.64 1.17 3.55 1.16 2.86 0.61 3.26 0.87 3.53 1.01 2.90 1.38 
Negative Feelings 3.18 0.98 3.11 1.04 3.46 0.99 3.07 1.01 3.43 1.09 3.18 0.80 2.86 1.03 3.13 0.76 3.00 1.06 
Mobility  3.61 1.03 4.08 1.00 3.47 1.00 3.95 1.00 3.58 1.03 3.10 0.86 3.16 0.91 3.69 0.92 3.02 1.10 
Activities of Living 3.39 1.02 3.52 1.09 2.95 0.84 3.59 0.96 3.48 1.17 3.51 0.87 3.74 1.08 3.36 0.85 2.92 1.25 
Depend Medication 3.31 1.28 3.51 1.33 3.39 1.34 2.98 1.17 3.59 1.27 4.42 0.78 2.88 0.95 3.29 1.16 2.22 1.19 
Working Capacity  3.30 1.08 3.31 1.21 2.97 1.04 3.57 1.07 3.40 1.30 3.58 0.80 3.05 0.89 3.44 0.88 2.89 1.32 
Relationships 3.35 1.05 3.25 1.37 2.92 0.80 3.60 1.02 3.55 1.06 3.40 0.91 3.82 1.10 3.31 0.78 3.27 1.17 
Social Support 3.24 0.99 3.76 1.12 2.82 0.74 3.44 1.09 3.15 1.13 3.24 0.94 3.10 0.69 3.25 0.85 3.00 1.02 
Sex Life 2.86 1.11 2.70 1.34 2.52 0.95 3.07 1.15 2.99 1.26 3.05 0.98 3.13 0.92 2.93 0.94 2.65 1.21 
Social Inclusion 3.26 1.08 3.98 0.97 2.64 0.99 3.60 1.02 3.20 1.23 3.09 0.89 3.06 1.03 3.20 0.83 3.14 1.12 
Safety & Security 3.04 0.97 3.65 0.92 2.76 0.86 3.21 0.98 3.01 1.03 2.62 1.02 3.14 0.75 2.75 0.78 3.09 1.10 
Home Environment 3.38 0.97 4.01 0.92 2.94 0.70 3.54 1.07 3.55 1.02 3.57 0.93 3.18 0.76 3.12 0.91 3.27 1.07 
Financial Resources 2.47 1.08 2.99 1.37 2.15 0.96 2.45 0.95 2.64 1.18 2.72 0.96 2.67 0.75 2.35 0.94 1.42 0.69 
  
29 
Health & Social Care 3.31 0.94 4.01 0.94 3.03 0.66 3.54 0.95 3.10 1.11 3.47 0.82 3.13 0.78 3.00 0.83 3.00 0.95 
Information  Skills 3.11 1.06 4.03 0.89 2.65 0.84 3.21 1.02 2.75 1.07 2.72 0.78 3.57 1.05 3.09 0.76 2.31 1.37 
Recreation / Leisure 2.91 0.99 3.42 1.10 2.70 0.82 2.98 1.01 2.98 1.07 2.49 0.90 3.13 0.80 2.74 0.84 2.52 1.09 
Environment 3.10 0.90 3.81 0.80 2.83 0.81 3.07 0.98 3.34 0.80 2.73 0.79 3.15 0.74 2.95 0.73 2.65 1.05 
Transport  3.22 0.95 3.80 1.09 3.01 0.65 3.19 0.93 3.23 1.07 3.46 0.87 3.15 0.74 2.88 0.90 3.31 1.09 
Spiritual 3.17 1.06 3.32 1.19 2.69 1.05 3.77 0.99 3.18 1.02 3.17 0.92 3.20 0.92 2.97 0.84 3.06 1.04 
Forgiveness 3.15 1.37 4.07 1.35 2.23 1.06 3.54 1.29 3.20 1.41 3.13 1.17 2.84 1.32 3.20 1.15 2.86 1.47 
Fear of the Future 3.08 1.29 3.48 1.16 2.32 1.01 3.12 1.25 3.52 1.36 4.24 1.09 2.74 1.36 3.06 1.05 2.60 1.36 
Death & Dying 3.26 1.29 3.85 1.06 2.90 1.17 3.37 1.32 3.56 1.44 3.26 1.22 3.25 1.30 3.21 1.18 1.97 1.19 
General QoL 3.23 0.94 3.64 1.08 2.96 0.75 3.47 0.87 3.43 1.14 3.32 0.84 2.93 0.83 3.02 0.86 2.86 0.87 
General Health 2.90 1.05 3.24 1.13 2.57 0.91 3.10 1.09 3.07 1.25 2.90 1.02 2.86 0.88 2.78 0.94 2.60 0.97 
Physical Domain 12.91 3.39 13.85 3.63 12.17 3.64 13.38 3.00 14.13 3.38 13.48 2.67 11.67 2.72 13.11 3.00 9.89 3.40 
Psychological Domain 12.84 2.83 13.80 3.03 11.97 3.02 13.54 2.76 12.94 2.88 12.94 2.04 12.74 2.65 12.66 2.33 11.38 3.01 
Independence Domain 13.61 3.40 14.45 3.59 12.78 3.67 14.08 3.09 14.08 3.68 14.63 2.10 12.84 2.84 13.78 3.15 11.05 3.63 
Social Domain 12.69 3.14 13.64 3.83 10.88 2.40 13.69 3.35 12.88 3.44 12.80 2.44 13.10 2.53 12.70 2.48 12.06 3.16 
Environment Domain 12.27 2.59 14.90 2.71 11.04 2.16 12.60 2.40 12.30 2.48 11.90 1.77 12.56 1.98 11.45 2.10 10.80 2.19 
Spirituality Domain 12.64 3.58 14.73 3.46 10.13 2.74 13.79 3.37 13.44 3.95 13.80 2.93 12.02 3.57 12.45 2.87 10.54 2.89 
 
 
 
